Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL and PTSC settlement Or Or ...

I see a few possibilities here:

  1. TPL vs PTSC settlement - TPL has no need to continue the appeal. If we settled should we not expect to see a new Master Agreement with amendments? Or a new agreement outside of the MA? If not, why not? Proove to shareholders you are watching out for them
  2. TPL ploy - TPL never intended to file a brief to waste time against PTSC and whoever else (Moore, T3, Chet, et al)
  3. TPL still has the opportunity to file the opening brief by July 5th

If number one transpired I would expect to see an 8k referencing an amended MA weighted back equaly or in PTSC's favor. Or an 8k referencing a new agreement outside the MA detailing new MMP audit controls. Something to show the shareholders of this company the BOD is learning.

Give prospective shareholders a reason to begin a position.

GLTAL

Share
New Message
Please login to post a reply